Revenue: The sum of all revenue fields included for a company's operating activities.
Adverum Biotechnologies, Inc. (ADVM) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
-- |
$-49.19M |
|
-- |
|
-- |
|
$49.85M |
|
$-49.85M |
|
$0.66M |
|
$-49.19M |
|
$-49.19M |
|
$-49.19M |
|
$-49.19M |
|
$-49.19M |
|
$-49.19M |
|
$-49.85M |
|
$-49.41M |
|
21.01M |
|
21.01M |
|
$-2.34 |
|
$-2.34 |
|
| Balance Sheet Financials | |
$48.39M |
|
$10.81M |
|
$47.79M |
|
$96.18M |
|
$31.36M |
|
-- |
|
$85.04M |
|
$116.40M |
|
$-20.22M |
|
$-20.22M |
|
$-20.22M |
|
20.98M |
|
| Cash Flow Statement Financials | |
$-81.54M |
|
$63.18M |
|
$0.12M |
|
$62.63M |
|
$44.39M |
|
$-18.23M |
|
$5.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-81.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
243.29% |
|
243.29% |
|
-51.15% |
|
243.29% |
|
$-0.96 |
|
$-3.90 |
|
$-3.88 |
|